hotspot -WSS

hotspot

author：knowledge 2025-09-28 23:10:46 - browse：91543

Kuldeep Singh Rajput -- health tech coverage from STAT — Kuldeep Singh Rajput has left his role as CEO of Biofourmis. World Economic Forum

A month after conducting significant layoffs, Biofourmis is out a CEO: Kuldeep Singh Rajput, one of the company’s founders, has quietly stepped down from his role.

A Biofourmis spokesperson confirmed Rajput’s departure to STAT on Wednesday, and said that while the company hunts for a new CEO it will be helmed by a committee of executives overseen by new board member Ben Wanamaker, a partner at Biofourmis investor General Atlantic. The Boston-based company was valued at $1.3 billion following a $320 million Series D financing round which closed last summer and brought big names to Biofourmis: CVS Health was an investor, and Omar Ishrak, former CEO of Medtronic, and Sachin Jain, CEO of the SCAN Health Plan joined the board.

Founded in 2015, Biofourmis has been developing a dizzying array of tech-enabled care offerings, including home-based care services for hospitals, clinical trials support for biopharma companies, and a pipeline of software-based interventions for heart failure and other conditions.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Patients, doctors press FTC to beef up hospital merger scrutiny

Wikipedia

WSS

'A game

Covid’s new normal has set in amid another rise in cases

The struggle to figure out which patients 'deserve' Wegovy

Roche’s Alnylam deal shows drug firms interested in heart drugs

Bronny James, LeBron's son, suffers cardiac arrest during basketball practice at USC

Assistant physicians can help address the primary care shortage

focus

hotspot

explore

After affirmative action ruling, medical educators look to 'holistic review'

The haunting brain science of long Covid

What does generative AI mean for health care? We asked experts

What to watch for from Zogenix and Amicus clinical trials

Medicare proposal to cover medical devices draws a mixed reaction

Biogen says it will cut costs by $700 million, slash 1,000 jobs

United colonoscopy coverage change 'may cost lives,' doctors say

House panel takes first step toward fixing drug shortages

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

A new crop of companies is reshaping the health data economy

focus

Neurocrine congenital adrenal hyperplasia trial succeeds

CDC Director Mandy Cohen on transparency, trust, and health

Truvian presents data for its desktop blood

Will the FTC rein in IQVIA's health data empire?

CDC Director Mandy Cohen on transparency, trust, and health

The unintended consequences of overturning Roe v. Wade

Wikipedia

focus

leisure time

explore